U.S. Markets open in 3 hrs 7 mins
  • S&P Futures

    3,419.75
    -12.75 (-0.37%)
     
  • Dow Futures

    28,030.00
    -104.00 (-0.37%)
     
  • Nasdaq Futures

    11,645.00
    -46.25 (-0.40%)
     
  • Russell 2000 Futures

    1,601.10
    -2.00 (-0.12%)
     
  • Crude Oil

    40.13
    +0.10 (+0.25%)
     
  • Gold

    1,918.00
    -11.50 (-0.60%)
     
  • Silver

    24.87
    -0.37 (-1.47%)
     
  • EUR/USD

    1.1839
    -0.0028 (-0.2368%)
     
  • 10-Yr Bond

    0.8160
    0.0000 (0.00%)
     
  • Vix

    29.53
    +0.18 (+0.61%)
     
  • GBP/USD

    1.3114
    -0.0030 (-0.2269%)
     
  • USD/JPY

    104.6670
    +0.1070 (+0.1023%)
     
  • BTC-USD

    12,923.48
    +1,866.47 (+16.88%)
     
  • CMC Crypto 200

    259.01
    +14.12 (+5.77%)
     
  • FTSE 100

    5,746.47
    -30.03 (-0.52%)
     
  • Nikkei 225

    23,474.27
    -92.73 (-0.39%)
     

Intellipharmaceutics: Fiscal 3Q Earnings Snapshot

·1 min read

TORONTO (AP) _ Intellipharmaceutics International Inc. (IPCIF) on Thursday reported fiscal third-quarter net income of $1 million, after reporting a loss in the same period a year earlier.

The Toronto-based company said it had profit of 4 cents per share.

The extended-release drug developer posted revenue of $328,800 in the period. Its adjusted revenue was $329,000.

In the final minutes of trading on Thursday, the company's shares hit 10 cents. A year ago, they were trading at 15 cents.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IPCIF at https://www.zacks.com/ap/IPCIF